Sanofi Settles Obesity Drug Class Action For $40M

Law360, Los Angeles (September 19, 2013, 9:17 PM EDT) -- French pharmaceutical giant Sanofi-Aventis SA has agreed to pay $40 million to settle a class action brought by investors who claim the company withheld information about anti-obesity drug Zimulti's link to severe psychiatric problems, according to documents filed in New York federal court on Thursday.

The agreement, which still requires court approval, comes six months after a New York federal judge certified the class of investors, finding the lead plaintiffs’ securities fraud claims were typical of the class as a whole.

U.S. District Judge George B....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In re: sanofi-aventis Securities Litigation


Case Number

1:07-cv-10279

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

George B. Daniels

Date Filed

November 13, 2007

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.